首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.
【2h】

Synergy of fosmidomycin (FR-31564) and other antimicrobial agents.

机译:磷霉素(FR-31564)与其他抗菌剂的协同作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fosmidomycin (FR-31564), a phosphonic acid derivative, was combined with cefazolin, cephalexin, ampicillin, carbenicillin, ticarcillin, gentamicin, and trimethoprim. Synergy between fosmidomycin and penicillins or cephalosporins was found for 37 to 52% of the Enterobacteriaceae tested. Synergy with trimethoprim was found against 55% of bacteria isolated, but only 17% of the strains showed synergy between formidomycin and gentamicin. Synergy between fosmidomycin and ticarcillin was shown for 35% of the Pseudomonas isolates. Cefazolin-, ampicillin-, and gentamicin-resistant isolates of various species were synergistically inhibited by fosmidomycin, as were ticarcillin- and gentamicin-resistant isolates. Antagonism was not encountered. This study illustrates another example of synergistic activity of compounds which attack different mechanisms in bacterial cells.
机译:将膦酸衍生物膦酰胺(FR-31564)与头孢唑林,头孢氨苄,氨苄西林,羧苄青霉素,替卡西林,庆大霉素和甲氧苄啶混合。在测试的肠杆菌科细菌中,发现磷霉素与青霉素或头孢菌素之间具有协同作用,占37%至52%。发现与甲氧苄啶具有协同作用,可分离出55%的细菌,但只有17%的菌株显示甲虫霉素和庆大霉素具有协同作用。 35%的假单胞菌分离株显示磷霉素和替卡西林之间具有协同作用。耐新霉素的耐头孢唑啉,氨苄青霉素和庆大霉素的分离株,耐替卡西林和庆大霉素的分离株被协同抑制。没有遇到对抗。该研究说明了攻击细菌细胞中不同机制的化合物的协同活性的另一个例子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号